Petros Pharmaceuticals, Inc. Derivative Liability
Petros Pharmaceuticals, Inc. (PTPI) had Derivative Liability of $0 as of 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2026-04-15
- 2024-12-31: Derivative Liability $0.00.
- 2024-06-30: Derivative Liability $202.00K.
- 2024-03-31: Derivative Liability $1.82M.
- 2023-12-31: Derivative Liability $3.55M.
| Period end | Derivative Liability |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-04-15 |
| 2024-06-30 | $202.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.82M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.55M 10-K · filed 2025-03-31 |
| 2023-09-30 | $6.57M 10-Q · filed 2023-11-15 |
| 2021-12-31 | $460.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $250.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.22M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $4.51M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $9.89M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |